Hyderabad: Bharat Biotech International Ltd said Friday it has reached an equitable pricing agreement with Gavi, the Vaccine Alliance, and UNICEF for the world’s first malaria vaccine. Bharat Biotech will cut the price of its Mosqivac malaria vaccine by around 40 per cent under an agreement with Gavi and UNICEF from early 2027.